Polycystic kidney disease: Etiology, pathogenesis, and treatment

Disease-a-Month

Volumn 41, Issue 11, 1995, Pages 693-765

  Martinez, John R ^a   Grantham, Jared J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CELL PROLIFERATION; CHROMOSOME 16; DIALYSIS; DIET THERAPY; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; NEPHROLITHIASIS; PATHOGENESIS; POTASSIUM DEFICIENCY; REVIEW;

ANIMAL; CHILD; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; INFANT; INFANT, NEWBORN; KIDNEY; POLYCYSTIC KIDNEY DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; PROGNOSIS;

EID: 0028869162     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(05)80007-0     Document Type: Article

References (292)

1. Renal cysts in pediatric autopsy material
2. Simple renal cysts in children: diagnosis and follow-up with US
3. An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases
4. Benign renal cysts and renal function
5. Solitary renal cysts: experience with 100 cases
6. Solitary renal cyst with segmental ischemia and hypertension
7. Solitary renal cyst, hypertension, and renin
8. Solitary intrarenal cyst: correctable cause of hypertension
9. Hematuria and massive calycovenous reflux secondary to benign renal cyst
10. Remission of erythrocytosis after drainage of a solitary renal cyst
11. Renal mass associated with polycythemia
12. Renal cyst causing afferent loop obstruction and acute pancreatitis
13. Infected solitary cyst of the kidney: report of a case and review of the literature
14. Perforation of a suppurative solitary cyst
15. Pyelocalyceal obstruction due to a renal cyst
16. Urinary obstruction due to renal cysts
17. Calyceal obstruction due to parapelvic cyst
18. Cysts and cystic kidneys
19. The pathogenesis of drug-induced renal cystic disease
20. Accelerated renal cyst development in deconditioned germ-free rats
21. Models of cysts and cystic kidneys
22. Understanding human cystic disease through experimental models
23. Association of hypokalemia, aldosteronism and renal cysts
24. A classification of renal cysts
25. Glutaric acidemia type II and defects in the mitochondrial respiratory chain
26. Acquired cystic disease: replacing one kidney disease with another
27. Acquired cystic kidney disease
28. Acquired cystic disease: mechanisms and manifestations
29. Inherited polycystic kidney disease in children
30. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980
31. Cystic renal diseases in children
32. Autosomal recessive polycystic kidney disease: issues regarding the variability of clinical presentation
33. Polycystic kidney disease: a predominance of giant nephrons
34. Cyst formation and growth in autosomal dominant polycystic kidney disease
35. Why cysts grow
36. Ultrastructure and function of cysts from human adult polycystic kidneys
37. Pathogenesis of renal cyst expansion: opportunities for therapy
38. Histogenesis of renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study
39. Composition of fluid in twelve cysts of a polycystic kidney
40. Macropuncture study of polycystic disease in adult human kidneys
41. The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease
42. Expression of clusterin in human renal disease
43. Elevated c-myc protooncogene expression in the autosomal recessive polycystic kidney disease
44. Localization of overexpressed c-myc mRNA in kidneys of the cpk mouse
45. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6j (cpk) mouse
46. Sequential protooncogene expression in regenerating kidney following acute renal injury
47. C-myc as an indicator of polycystic kidney disease in transgenic mice
48. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40
49. Renal cyst formation and multifocal neoplasia in transgenic mice carrying the simian virus 40 early region
50. Cell biology of human autosomal dominant polycystic kidney disease
51. C-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BI/6J-cpk mouse
52. Differential growth factor-induced modulation of proteoglycans synthesized by normal human versus cyst derived cells
53. Chemical modification of cell proliferation and fluid secretion in renal cysts
54. Polycystic kidney disease: neoplasia in disguise
55. Epitheilal hyperplasia in human polycystic kidney disease: its role in pathogenesis and risk of neoplasia
56. Injury and development in polycystic kidney disease
57. Reversed polarity of Na-K-ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia
58. Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease
59. Fluid secretion in the nephron: relation to renal failure
60. Hydrocortisone-induced cystic metanephric maldevelopment in serum-free organ culture
61. Secretory NaCl and volume flow in renal tubules
62. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts
63. In vitro fluid secretion by epitheilum from polycystic kidneys
64. Arginine vasopressin stimulates net fluid secretion in a polarized subculture of cyst forming MDCK cells
65. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP
66. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP
67. A method to measure the rate of net fluid secretion by monolayers of cultured renal epithelial cells
68. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease
69. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro
70. Cystic fibrosis
71. Reversible tubular cell and basement membrane changes in drug-induced renal cystic disease
72. Basement membrane antigens in renal polycystic disease
73. Tubular cell and basement membrane changes in polycystic kidney
74. Tubular basement membrane changes in 2-amino-4,5-diphenylthiazole-induced polycystic kidney disease
75. Decreased de novo synthesis of proteoglycans in drug-induced renal cystic disease
76. Altered synthesis of proteoglycans by cyst derived cells from autosomal-dominant polycystic kidneys
77. Differential growth factor-induced modulation of proteoglycans synthesized by normal human versus cyst-derived cells
78. The basement membrane in pathology
79. Role of collagenous matrices in the adhesion and growth of cells
80. Extracellular matrix regulation of cell-cell communication and tissue specific gene expression in primary liver cultures
81. Biology of polycystic kidney disease
82. Tubular basement membrane change occurs pari passu with the development of cyst formation
83. Genetics and biochemistry of variant human phenotypes
84. Bilateral polycystic disease of the kidney: a followup of 284 patients and their families
85. Autosomal dominant polycystic kidney disease-more than a renal disease
86. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16
87. Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers
88. The diagnosis and prognosis of autosomal dominant polycystic kidney disease
89. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease
90. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
91. Linkage heterogenicity of autosomal dominant polycystic kidney disease
92. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23
93. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease
94. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease
95. Localization of a mutation producing autosomal dominant polycystic kidney disease without renal failure
96. Polycystic kidney disease re-evaluated: a population based study
97. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1
98. The role of computed tomography in the evaluation of adult polycystic kidney disease
99. The current radiologic approach to renal cysts
100. The genetics of cystic diseases of the kidney
101. Prenatal diagnosis of autosomal dominant polycystic kidney disease with a DNA probe
102. Prediction of likelihood of polycystic kidney disease in the fetus when a parent has autosomal dominant kidney disease
103. Gene testing in autosomal dominant polycystic kidney disease: results of National Kidney Foundation workshop
104. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease
105. Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors
106. Autosomal dominant polycystic kidney disease: symptoms and clinical findings
107. Renal manifestations: complication management and long-term outcome of autosomal dominant polycystic kidney disease
108. Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease
109. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease
110. Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease
111. Polycystic kidney disease: prospective analysis of nonazotemic patients and family members
112. An arterio-venous fistula in a polycystic kidney: a case of acute renal failure and hematuria
113. Nephrotic syndrome and rapid renal failure in autosomal dominant polycystic kidney disease
114. IgA nephropathy and polycystic kidney disease
115. Membranous glomerulonephritis associated with autosomal dominant polycystic kidney disease
116. A membranous nephropathy associated with adult polycystic kidney disease
117. Polycystic kidney disease and seatbelts
118. Seat belts and polycystic kidneys
119. Management of pain and hemorrhage in polycystic kidney disease
120. Treatment of gross hematuria in autosomal dominant polycystic kidney disease with aprotinin and desmopressin acetate
121. Transcatheter infarction of a polycystic kidney for control of recurrent hemorrhage
122. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease
123. Medical progress: autosomal dominant polycystic kidney disease
124. Urinary lipid bodies in polycystic kidney disease
125. Causes of death in autosomal dominant polycystic kidney disease
126. Renal pain in polycystic kidney disease: when the hurt won't stop
127. MRI of hemorrhagic renal cysts in polycystic didney disease
128. Surgical management of painful polycystic kidneys
129. Cyst decompression surgery for autosomal dominant polycystic kidney disease
130. Percutaneous reduction of cyst volume of polycystic kidney disease: effects on renal function
131. Percutaneous resection of renal cysts: a long-term follow-up
132. Diagnostic aspects, functional significance and therapy of simple renal cysts
133. Effects of topical installation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease
134. Adult polycystic kidney disease: studies of the defect in urine concentration
135. The clinical utility of renal concentrating capacity in polycystic kidney disease
136. A new method for studying human polycystic kidney disease epithelia in culture
137. Renal stone disease in autosomal dominant polycystic kidney disease
138. The association of nephrolithiasis and autosomal dominant polycystic kidney disease
139. The role of computed tomography in the evaluation of adult polycystic kidney disease
140. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients
141. Renal infection in autosomal dominant polycystic kidney disease
142. Renal infections in autosomal dominant polycystic kidney disease
143. Gallium-67 scintigraphy for the diagnosis and localization of perinephric abscesses
144. pH-Dependent accumulation of clindamycin in polycystic kidneys
145. Concentration of antibiotics in simple renal cysts
146. Ciprofloxacin activity in cyst fluid from polycystic kidneys
147. Trimethoprimsul famethoxazole in cyst fluid from autosomal dominant polycystic kidneys
148. Cyst fluid antibiotic concentrations in autosomal dominant polycystic kidney disease
149. Urinary tract infection requiring nephrectomy in a patient with autosomal dominant polycystic kidney disease despite ciprofloxacin therapy
150. Autosomal dominant polycystic kidney disease
151. The spectrum of autosomal dominant polycystic kidney disease in children
152. Renal structure and hypertension in autosomal dominant polycystic kidney disease
153. Hypertension in autosomal dominant polycystic kidney disease
154. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: 10-year follow-up in a five-generation kindred
155. Renal artery occlusion and malignant hypertension in polycystic kidney disease
156. The renin-angiotensinaldosterone system and autosomal dominant polycystic kidney disease
157. Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease
158. Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study
159. Liver changes and complications in adult polycystic kidney disease
160. Frequency of hepatic cysts in adult polycystic kidney disease
161. Computed tomography of adult polycystic disease
162. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease
163. Hepatic cysts in autosomal dominant polycystic kidney disease
164. The liver in autosomal dominant polycystic kidney disease: implications for pathogenesis
165. Polycystic liver disease: a study of cyst fluid constituents
166. Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin
167. Treatment of highly symptomatic polycystic liver disease: preliminary experience with a combined hepatic resection fenestration procedure
168. Polycystic liver disease: quantitation of parenchymal and cyst volume from computed tomography and clinical correlates of hepatic cysts
169. Hepatic cyst infection in autosomal dominant polycystic kidney disease
170. Cholangiocellular carcinoma in polycystic kidney and liver disease
171. Single and multiple pyogenic liver abscesses: natural history, diagnosis, and treatment with emphasis on percutaneous drainage
172. Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease
173. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease
174. Incidence of diverticular disease in patients with polycystic kidney disease
175. Epidemiology of adult ploycystic kidney disease, Olmsted County, Minn.: 1935-1980
176. The association of polycystic kidney disease with intracranial aneurysms and other related disorders
177. Occult intracranial aneurysms in polycystic kidney disease
178. General features of autosomal dominant polycystic kidney disease: management of unruptured intracranial aneurysms
179. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease
180. Intracranial aneurysms in autosomal dominant polycystic kidney disease
181. Value of magnetic resonance angiography for detection of intracranial aneurysms in autosomal dominant polycystic kidney disease
182. Subarachnoid hemorrhage
183. Recurrent rupture of intracranial aneurysm in autosomal dominant polycystic kidney disease
184. Screening for occult intracranial aneurysms in polycystic kidney disease: interim guidelines
185. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen
186. Increased incidence of coronary artery aneurysms in patients with autosomal dominant polycystic kidney disease (ADPKD)
187. Polycystic kidney and abdominal aortic aneurysms
188. Polycystic kidneys and abdominal aortic aneurysms
189. General features of autosomal dominant polycystic kidney disease: epidemiology
190. Familiar clustering of aortic dissection in polycystic kidney disease
191. Cardiovascular abnormalities associated with autosomal dominant polycystic kidney disease
192. Echocardiographic findings in autosomal dominant polycystic kidney disease
193. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study
194. Cystic and developmental diseases of the kidney
195. Cranial computed tomography and magnetic resonance imaging in autosomal dominant polycystic kidney disease
196. Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease
197. Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease
198. Is gender a determinant for evolution of renal failure?
199. Autosomal dominant polycystic kidney disease in blacks: clinical course and effect of sickle-cell hemoglobin
200. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
201. Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease
202. Hypokalemic nephropathy-a clue to cystogenesis?
203. Accelerated progression of inherited polycystic kidney disease (PKD) caused by non-genetic interventions
204. Renal cystic disease and ammoniagenesis in Han: SPRD rats
205. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation
206. Survival rates of 2,728 patients with end stage renal disease
207. Regional citrate anticoagulation in chronic hemodialysis patients
208. Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease
209. Renal transplantation and autosomal dominant polycystic kidney disease 20 years' experience
210. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation
211. Polycystic disease of kidneys and liver presenting in childhood
212. Autosomal recessive polycystic kidney disease
213. Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen
214. The severe perinatal phenotype of ARPKD (autosomal recessive polycystic kidney disease) maps to chromosome 6p21-cen
215. Autosomal recessive polycystic kidney disease
216. Autosomal recessive polycystic kidney disease
217. Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data
218. Polycystic kidney diseases in childhood
219. Polycystic kidney disease in the first year of life
220. Clues and pitfalls in the early prenatal diagnosis of “late onset” infantile polycystic kidney
221. Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein
222. Infantile polycystic kidney disease: observations from attempts at prenatal diagnosis
223. A tale of two prior probabilities-avoiding the false positive antenatal diagnosis of autosomal recessive polycystic kidney disease
224. Caroli disease: high-frequency US and pathologic findings
225. Congenital hepatic fibrosis evolving morphology
226. Infantile polycystic disease of the liver and kidneys
227. Morphometric analysis of liver lesions in cystic diseases of childhood
228. The ductal plate malformation
229. Caroli's disease in congenital hepatic fibrosis and infantile polycystic disease
230. Prenatal diagnosis of autosomal recessive polycystic kidneys disease: variable outcome within one family
231. Renal cystic disease of infancy: results of histochemical studies; a report of the Southwest Pediatric Nephrology Study Group
232. Peritoneal dialysis in pediatric patients
233. Nutritional management of pediatric patients on chronic dialysis
234. The use of cadaver kidneys for transplantation in young children
235. Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data
236. Caroli's disease in congenital hepatic fibrosis and infantile polycystic disease
237. Congenital hepatic fibrosis in children
238. Polycystic disease and hepatic fibrosis in children: renal function studies
239. Autosomal recessive polycystic kidney disease
240. Acquired cystic kidney disease of the kidneys a hazard of long-term intermittent maintenance haemodialysis
241. Acquired renal cysts in uremic patients-in vivo demonstration by computed tomography
242. Multicystic transformation of kidneys in chronic renal failure
243. Clinical characteristics and diagnostic considerations in acquired renal cystic disease
244. Acquired cystic disease of the kidney in association with chronic ambulatory peritoneal dialysis
245. Acquired cystic kidney disease: the hormonal hypothesis
246. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers
247. Regression of acquired cystic disease of the kidney after successful renal transplantation
248. CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients
249. Acquired renal cystic in renal transplant recipients
250. Severity of acquired renal cystis in native kidneys and renal allograft with long-standing poor function
251. Acquired cystic disease in chronically rejected renal transplants
252. Cystic transformation in native kidneys in renal allograft recipients with long-standing good function
253. Acquired cystic disease and renal adenocarcinoma following renal transplantation
254. Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients
255. Renal cell carcinoma in uremic acquired renal cystic disease: incidence, detection, and management
256. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study
257. Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients
258. Acquired renal cystic disease
259. Acquired cystic disease of kidney in chronic dialysis patients
260. Acquired cystic disease of the kidney analyzed by microdissection
261. Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys
262. Acquired renal cystic disease in end-stage renal disease an autopsy study of 155 cases
263. Spontaneous subcapsular and perinephric hemorrhage in end-stage kidney disease: clinical and CT findings
264. Massive renal and retroperitoneal hemorrhage in a case of acquired renal cystic disease with atypical epithelial cell proliferation
265. Uncontrolled hypertension and hyperreninemia after hemorrhage in a patient with end-stage renal disease and acquired renal cysts
266. Acquired renal cystic disease in hemodialysis: a study of 82 nephrectomies in young patients
267. Acquired cystic disease of the end-stage kidney
268. Cyst infection in acquired renal cystic disease
269. Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis
270. Acute flank pain in dialysed patients: demonstration of hydronephrosis by computer tomography
271. Ureteric pain in patients with chronic renal failure on hemodialysis
272. Uremic acquired cystic disease of the kidney
273. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis
274. Prediction of carcinoma in acquired cystic disease as a function of weight
275. Renal cancer complicationg acquired cystic kidney disease
276. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasound
277. Renal cell carcinoma at autopsy
278. Renal neoplasia
279. Acquired cystic disease of the kidneys a hazard of long-term intermittent maintenance haemodialysis
280. Acquired cystic disease of the kidney: a management dilemma
281. Acquired renal cystic disease in the end stage kidney: urological implications
282. Renal cell carcinoma of the native kidney after renal transplantation-a case report and review of the literature
283. Erythrocytosis in patients on long-term hemodialysis
284. Multicystic transformation of kidneys in chronic renal failure
285. Clinical characteristics and diagnostic considerations in acquired renal cystic disease
286. Genetics and biochemistry of variant human phenotypes